奥门丁可以增加葡萄糖的摄入量,但不能增加人类肌管中的胰岛素敏感性,这些肌管依赖于细胞外的乳酸转移蛋白
Jacqueline M Ratter-Rieck1,2, Alexandra Zepina1,2, Corinna Niersmann1,2
1Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Obesity facts
|November 11, 2024
概括
奥门丁 (intlectin-1) 增强了人类骨肌细胞的基础葡萄糖吸收,独立于胰岛素信号传递. 乳酸转化可能会影响体外表现.
科学领域:
- 内分泌学和新陈代谢学
- 阿迪波基因研究研究
- 骨肌肉生理学 骨肌肉生理学
背景情况:
- 奥门丁 (intlectin-1) 是一种与胰岛素敏感性相关的阿迪波金.
- 它在骨肌肉中的作用机制在很大程度上仍未被探索.
- 以前的研究集中在脂肪细胞上,而不是肌肉组织.
研究的目的:
- 为了研究奥门丁对原发性人类髓管中的胰岛素敏感性和新陈代谢的影响.
- 探索奥门丁对葡萄糖吸收,信号通路和骨肌肉中的脂质代谢的影响.
- 为了确定omentin作用的潜在调节器.
主要方法:
- 主要的人类肌管被用奥门丁 (0.5或2μg/mL) 治疗.
- 检测包括蛋白质检测,葡萄糖摄取,乳酸释放和脂质学.
- 带有和没有乳酸转移素的研究效应.
主要成果:
- 奥门丁没有改变胰岛素信号传递 (IRS1,AKT酸化).
- 基础葡萄糖摄入量增加,但胰岛素刺激摄入量保持不变.
- 乳酸释放增加,表明增强的葡萄糖分解;三糖醇水平上升.
- 乳酸转素抵消了奥门丁诱导的葡萄糖吸收.
结论:
- 奥门丁增加了骨肌肉的基础葡萄糖吸收,这表明有组织特异性的影响.
- 奥门丁的机制可能涉及乳转移素,这可能解释了各种疾病的关联.
- 这些发现突显了奥门丁在骨肌肉代谢和胰岛素敏感性中的作用.
更多相关视频
相关概念视频
Hormones Regulating Blood Glucose
3.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.1K
Glucose Absorption Into the Small Intestine
31.3K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.3K
Glucagon-like Receptor Agonists
300
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
300
Insulin: The Receptor and Signaling Pathways
1.1K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.1K
Glucose Transporters
22.5K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.5K
Insulin Secretory Vesicles
4.8K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.8K


